

Advance Aging Biology Through Policy: Alliance for Longevity Initiatives
Aging research is advancing fast… policy will decide whether it reaches patients.
Want to discover how legislation could unlock the next generation of aging therapeutics and advance public health?
Join the Aging Initiative for a Conversation on Aging Policy!
💰 Only ~1% of the NIH budget directly supports aging biology research, despite aging being the largest risk factor for nearly every major chronic disease. As breakthroughs in geroscience accelerate, policy will determine whether these discoveries translate into tangible health and economic benefits.
Join us for a conversation with Dylan Livingston, who leads the Alliance for Longevity Initiatives (A4LI), the first U.S. nonprofit dedicated to advancing pro-longevity policies on Capitol Hill. He’ll share how new efforts in Washington are shaping the future of aging research and what’s next for translational aging policy.